Sask. Ministry of Health estimates 12,000 people suffer from blood-borne illness Saskatchewan will soon be paying for six new drugs targeted at people who suffer from hepatitis C. The drugs have a 95 per cent success rate and can cure patients in as little as eight to 12 weeks. "These new medications offer a much better chance of curing hepatitis C, and vastly improve patients' quality of life," said Health Minister Jim Reiter in a news release.
The Ontario government has significantly increased the number of people who can be cured of this potentially fatal, liver-destroying virus by adding some expensive new drugs to its Ontario Public Drug Programs and expanding eligibility to people whose livers aren’t as severely damaged. Many people who need the treatment would be eligible for an Ontario drug program either because they’re over 65, they’re receiving disability or they have very low incomes.
The Health Care Authority on Monday reached a settlement agreement in a class action lawsuit that sought broader coverage of costly hepatitis C drugs for Medicaid patients in Washington state. The settlement has yet to be approved by a judge but lawyers are hopeful it will be soon. In the past several years, multiple pharmaceutical companies nationwide have developed direct-acting antiviral drugs that cure hepatitis C in more than 90 percent of patient
After legal battles and lobbying efforts, tens of thousands of people with hepatitis C are gaining earlier access to expensive drugs that can cure this condition. States that limited access to the medications out of concern over sky-high prices have begun to lift those restrictions — many, under the threat of legal action. And commercial insurers such as Anthem Inc. and United HealthCare are doing the same. Massachusetts is the latest state to decide t